Stephen J. Tulipano
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2024-05-07
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $458,640 | $1,598,481 |
| 2022 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $436,800 | $2,316,523 |
| 2021 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $416,000 | $3,101,566 |
| 2019 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $294,318 | $1,176,396 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.